This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bogatcheva, N. V. Articles by Agoulnik, A. I. Search for Related Content PubMed PubMed Citation Articles by Bogatcheva, N. V. Articles by Agoulnik, A. I.

GREAT/LGR8 Is the Only Receptor for Insulin-Like 3 Peptide

Department of Obstetrics and Gynecology (N.V.B., A.T., S.F., A.I.A.), Baylor College of Medicine, Houston, Texas 77030; and Institute of Human Genetics (W.E., I.M.A.), University of Göttingen, D-37073 Göttingen, Germany

Address all correspondence and requests for reprints to: Dr. Alexander I. Agoulnik, Department of Obstetrics and Gynecology, 6550 Fannin Street, Baylor College of Medicine, Houston, Texas 77030. E-mail: agoulnik{at}bcm.tmc.edu.

During male development testes descend from their embryonic intraabdominal position into the scrotum. Two genes, encoding the insulin-like 3 peptide (INSL3) and the GREAT/LGR8 G protein-coupled receptor, control the differentiation of gubernaculum, the caudal genitoinguinal ligament critical for testicular descent. It was established that the INSL3 peptide activates GREAT/LGR8 receptor in vitro. Mutations of Insl3 or Great cause cryptorchidism (undescended testes) in mice. Overexpression of the transgenic Insl3 causes male-like gubernaculum differentiation, ovarian descent into lower abdominal position, and reduced fertility in females. To address the question whether Great deletion complements the mutant female phenotype caused by the Insl3 overexpression, we have produced Insl3 transgenic mice deficient for Great. Such females had a wild-type phenotype, demonstrating that Great was the only cognate receptor for Insl3 in vivo. We have established that pancreatic HIT cells, transfected with the INSL3 cDNA, produce functionally active peptide. Analysis of five INSL3 mutant variants detected in cryptorchid patients showed that P49S substitution renders functionally compromised peptide. Therefore, mutations in INSL3 might contribute to the etiology of cryptorchidism. We have also showed that synthetic insulin-like peptides (INSL4 and INSL6) were unable to activate LGR7 or GREAT/LGR8.

This article has been cited by other articles:

				R. Ivell and R. Anand-Ivell Biology of insulin-like factor 3 in human reproduction Hum. Reprod. Update, July 1, 2009; 15(4): 463 - 476. [Abstract] [Full Text] [PDF]

				A. Kern and G. D. Bryant-Greenwood Characterization of Relaxin Receptor (RXFP1) Desensitization and Internalization in Primary Human Decidual Cells and RXFP1-Transfected HEK293 Cells Endocrinology, May 1, 2009; 150(5): 2419 - 2428. [Abstract] [Full Text] [PDF]

				A. Ferlin, D. Zuccarello, B. Zuccarello, M. R. Chirico, G. F. Zanon, and C. Foresta Genetic Alterations Associated With Cryptorchidism JAMA, November 19, 2008; 300(19): 2271 - 2276. [Abstract] [Full Text] [PDF]

				J.-I. Park, J. Semyonov, W. Yi, C. L. Chang, and S. Y. T. Hsu Regulation of Receptor Signaling by Relaxin A Chain Motifs: DERIVATION OF PAN-SPECIFIC AND LGR7-SPECIFIC HUMAN RELAXIN ANALOGS J. Biol. Chem., November 14, 2008; 283(46): 32099 - 32109. [Abstract] [Full Text] [PDF]

				C. Foresta, D. Zuccarello, A. Garolla, and A. Ferlin Role of Hormones, Genes, and Environment in Human Cryptorchidism Endocr. Rev., August 1, 2008; 29(5): 560 - 580. [Abstract] [Full Text] [PDF]

				M. A. Hossain, K. J. Rosengren, L. M. Haugaard-Jonsson, S. Zhang, S. Layfield, T. Ferraro, N. L. Daly, G. W. Tregear, J. D. Wade, and R. A. D. Bathgate The A-chain of Human Relaxin Family Peptides Has Distinct Roles in the Binding and Activation of the Different Relaxin Family Peptide Receptors J. Biol. Chem., June 20, 2008; 283(25): 17287 - 17297. [Abstract] [Full Text] [PDF]

				J.-I. Park, J. Semyonov, C. L. Chang, W. Yi, W. Warren, and S. Y. T. Hsu Origin of INSL3-mediated testicular descent in therian mammals Genome Res., June 1, 2008; 18(6): 974 - 985. [Abstract] [Full Text] [PDF]

				F. Nuti, E. Marinari, E. Erdei, M. El-Hamshari, M. G. Echavarria, E. Ars, G. Balercia, M. Merksz, C. Giachini, K. Z. M. Shaeer, et al. The Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 8 Gene T222P Mutation Does Not Cause Cryptorchidism J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 1072 - 1076. [Abstract] [Full Text] [PDF]

				H.E. Virtanen and J. Toppari Epidemiology and pathogenesis of cryptorchidism Hum. Reprod. Update, January 1, 2008; 14(1): 49 - 58. [Abstract] [Full Text] [PDF]

				S. Feng, N. V Bogatcheva, A. Truong, B. Korchin, C. E Bishop, T. Klonisch, I. U Agoulnik, and A. I Agoulnik Developmental Expression and Gene Regulation of Insulin-like 3 Receptor RXFP2 in Mouse Male Reproductive Organs Biol Reprod, October 1, 2007; 77(4): 671 - 680. [Abstract] [Full Text] [PDF]

				E. J. Hopkins, S. Layfield, T. Ferraro, R. A. D. Bathgate, and P. R. Gooley The NMR Solution Structure of the Relaxin (RXFP1) Receptor Lipoprotein Receptor Class A Module and Identification of Key Residues in the N-terminal Region of the Module That Mediate Receptor Activation J. Biol. Chem., February 9, 2007; 282(6): 4172 - 4184. [Abstract] [Full Text] [PDF]

				J. Novak, L. J. Parry, J. E. Matthews, L. J. Kerchner, K. Indovina, K. Hanley-Yanez, K. D. Doty, D. O. Debrah, S. G. Shroff, and K. P. Conrad Evidence for local relaxin ligand-receptor expression and function in arteries FASEB J, November 1, 2006; 20(13): 2352 - 2362. [Abstract] [Full Text] [PDF]

				E. E. Bullesbach and C. Schwabe The Mode of Interaction of the Relaxin-like Factor (RLF) with the Leucine-rich Repeat G Protein-activated Receptor 8 J. Biol. Chem., September 8, 2006; 281(36): 26136 - 26143. [Abstract] [Full Text] [PDF]

				A. Ferlin, A. Garolla, F. Rigon, L. Rasi Caldogno, A. Lenzi, and C. Foresta Changes in Serum Insulin-Like Factor 3 during Normal Male Puberty J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3426 - 3431. [Abstract] [Full Text] [PDF]

				S. Hombach-Klonisch, J. Bialek, B. Trojanowicz, E. Weber, H.-J. Holzhausen, J. D. Silvertown, A. J. Summerlee, H. Dralle, C. Hoang-Vu, and T. Klonisch Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells Am. J. Pathol., August 1, 2006; 169(2): 617 - 632. [Abstract] [Full Text] [PDF]

				A. Ferlin, N.V. Bogatcheva, L. Gianesello, A. Pepe, C. Vinanzi, A.I. Agoulnik, and C. Foresta Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization Mol. Hum. Reprod., June 1, 2006; 12(6): 401 - 406. [Abstract] [Full Text] [PDF]

				P Fu, P-J Shen, C-X Zhao, D J Scott, C S Samuel, J D Wade, G W Tregear, R A D Bathgate, and A L Gundlach Leucine-rich repeat-containing G-protein-coupled receptor 8 in mature glomeruli of developing and adult rat kidney and inhibition by insulin-like peptide-3 of glomerular cell proliferation. J. Endocrinol., May 1, 2006; 189(2): 397 - 408. [Abstract] [Full Text] [PDF]

				R. J.K. Anand-Ivell, V. Relan, M. Balvers, I. Coiffec-Dorval, M. Fritsch, R. A.D. Bathgate, and R. Ivell Expression of the Insulin-Like Peptide 3 (INSL3) Hormone-Receptor (LGR8) System in the Testis Biol Reprod, May 1, 2006; 74(5): 945 - 953. [Abstract] [Full Text] [PDF]

				R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31. [Abstract] [Full Text] [PDF]

				S. Feng, N. V. Bogatcheva, A. A. Kamat, A. Truong, and A. I. Agoulnik Endocrine Effects of Relaxin Overexpression in Mice Endocrinology, January 1, 2006; 147(1): 407 - 414. [Abstract] [Full Text] [PDF]

				B. M. C. McGowan, S. A. Stanley, K. L. Smith, N. E. White, M. M. Connolly, E. L. Thompson, J. V. Gardiner, K. G. Murphy, M. A. Ghatei, and S. R. Bloom Central Relaxin-3 Administration Causes Hyperphagia in Male Wistar Rats Endocrinology, August 1, 2005; 146(8): 3295 - 3300. [Abstract] [Full Text] [PDF]

				M. L. Halls, C. P. Bond, S. Sudo, J. Kumagai, T. Ferraro, S. Layfield, R. A. D. Bathgate, and R. J. Summers Multiple Binding Sites Revealed by Interaction of Relaxin Family Peptides with Native and Chimeric Relaxin Family Peptide Receptors 1 and 2 (LGR7 and LGR8) J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 677 - 687. [Abstract] [Full Text] [PDF]

				E. E. Bullesbach and C. Schwabe LGR8 Signal Activation by the Relaxin-like Factor J. Biol. Chem., April 15, 2005; 280(15): 14586 - 14590. [Abstract] [Full Text] [PDF]

				C. Liu, C. Kuei, S. Sutton, J. Chen, P. Bonaventure, J. Wu, D. Nepomuceno, F. Kamme, D.-T. Tran, J. Zhu, et al. INSL5 Is a High Affinity Specific Agonist for GPCR142 (GPR100) J. Biol. Chem., January 7, 2005; 280(1): 292 - 300. [Abstract] [Full Text] [PDF]

				J. Chen, C. Kuei, S. W. Sutton, P. Bonaventure, D. Nepomuceno, E. Eriste, R. Sillard, T. W. Lovenberg, and C. Liu Pharmacological Characterization of Relaxin-3/INSL7 Receptors GPCR135 and GPCR142 from Different Mammalian Species J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 83 - 95. [Abstract] [Full Text] [PDF]

				C. Liu, J. Chen, C. Kuei, S. Sutton, D. Nepomuceno, P. Bonaventure, and T. W. Lovenberg Relaxin-3/Insulin-Like Peptide 5 Chimeric Peptide, a Selective Ligand for G Protein-Coupled Receptor (GPCR)135 and GPCR142 over Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 7 Mol. Pharmacol., January 1, 2005; 67(1): 231 - 240. [Abstract] [Full Text] [PDF]

				C. Foresta, A. Bettella, C. Vinanzi, P. Dabrilli, M. C. Meriggiola, A. Garolla, and A. Ferlin A Novel Circulating Hormone of Testis Origin in Humans J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5952 - 5958. [Abstract] [Full Text] [PDF]

				G. Vinci, M.-N. Anjot, C. Trivin, H. Lottmann, R. Brauner, and K. McElreavey An Analysis of the Genetic Factors Involved in Testicular Descent in a Cohort of 14 Male Patients with Anorchia J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6282 - 6285. [Abstract] [Full Text] [PDF]

				A. A. Kamat, S. Feng, N. V. Bogatcheva, A. Truong, C. E. Bishop, and A. I. Agoulnik Genetic Targeting of Relaxin and Insulin-Like Factor 3 Receptors in Mice Endocrinology, October 1, 2004; 145(10): 4712 - 4720. [Abstract] [Full Text] [PDF]